Our mission is to accelerate scientific discovery through agentic AI built for how research actually works.

Enjamb's agentic AI platform redefines what biopharma R&D teams can accomplish. We give scientists and drug developers a powerful new way to discover, execute, and submit across the full drug program, automating the work behind every assay, every trial, and every regulatory filing.

Our vision is to become the one platform where every part of biopharma R&D happens, where agents run on top of the systems teams already use and carry a program all the way from discovery to FDA approval, accelerating progress on some of the most important questions humanity faces.